tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kelechi Chikere, 11 are a BUY (100%).
Analyst Kelechi Chikere, carries an average stock price target met ratio of 46.67% that have a potential upside of 49.06% achieved within 39 days. Previously, Kelechi Chikere worked at JEFFERIES.
Kelechi Chikere’s has documented 20 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ALT, Altimmune at 30-Dec-2021.
Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for ALT (ALTIMMUNE) at 12/23/2020. The price target of $24 was fulfilled within 56 days with a profit of $11.38 (90.17%) receiving and performance score of 16.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2020
$11
$8.18 (290.07%)
$14
2 months 1 days ago
(14-May-2026)
0/18 (0%)
$8.08 (276.71%)
Buy Since 02-Jun-2021
$25
$22.18 (786.52%)
$12
3 months 29 days ago
(16-Mar-2026)
0/25 (0%)
$21.38 (590.61%)
Buy Since 12-Nov-2024
$24
$21.18 (751.06%)
$26
11 months 2 days ago
(13-Aug-2025)
0/3 (0%)
$20.26 (541.71%)
Buy Since 25-Sep-2020
$18
$15.18 (538.30%)
$20
11 months 2 days ago
(13-Aug-2025)
3/14 (21.43%)
$14.26 (381.28%)
272
Buy Since 01-Jun-2020
$25
$22.18 (786.52%)
$25
2 years 24 days ago
(21-Jun-2024)
1/14 (7.14%)
$18.59 (290.02%)
37
What Year was the first public recommendation made by Kelechi Chikere?
